The company will introduce its innovative siliconized moulded glass vials, positioning itself as the only global supplier ...

Large reduction in COGS: By 2025, EnzeneX 2.0 expects to produce 40 kg/1000 L batches at $40/gram, redefining FCCM economics. Lower operational costs and higher productivity can lead to up to 50% ...

Artificial intelligence has emerged as a potential solution to inconsistent reporting of adverse events, which to this day ...

The Barcelona-based startup Sequentia Biotech has raised €10 million ($11 million) in a Series A round to finance the ...

The Barcelona-based startup Sequentia Biotech has raised €10 million ($11 million) in a Series A round to finance the development of its omics-based technology for use in biomedicine, agritech and ...

These results back up results from the TEMPO-3 trial, which tested tavapadon as an add-on therapy to levodopa and which also ...

The US biotech’s neurological drug candidate showed a reduction in disease progression of at least 50% and the company will ...

The US big pharma company Pfizer has voluntarily withdrawn the oral sickle cell disease treatment Oxbryta from the market and ...

Designed as a next generation cellulose-based virus removal filter, Planova™ S20N has demonstrated robust filtration ...

The small molecule drug arimoclomol (Miplyffa) has got the green light from the U.S. Food and Drug Administration (FDA) for ...

The Hong Kong headquartered company says its idiopathic pulmonary fibrosis drug performed well in a phase 2a trial and met ...

The series A financing will enable Nura Bio to advance its lead drug candidate into the next stage of clinical trials, ...